How can biosimilars change the trajectory of breast cancer therapy?

被引：9
|
作者：
Trapani, Dario [1 ,2 ]
Curigliano, Giuseppe [1 ,2 ]
机构：
[1] European Inst Oncol IRCCS, Div Early Drug Dev Innovat Therapies, Milan, Italy
[2] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2020年 / 20卷 / 05期
关键词：
Biosimilars; breast cancer; trastuzumab; similar biotherapeutic products; SBP; UHC; cancer policy; TRASTUZUMAB;
D O I：
10.1080/14737140.2020.1757438
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：325 / 328
页数：4
相关论文
共 50 条
  • [1] Biosimilars for breast cancer
    Zucchetti, Bruna Migliavacca
    Nicolo, Eleonora
    Curigliano, Giuseppe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (10) : 1015 - 1021
  • [2] Prevention Therapy for Breast Cancer: How Can We Do Better?
    Marie E. Wood
    Melissa Cuke
    Isabelle Bedrosian
    [J]. Annals of Surgical Oncology, 2019, 26 : 1970 - 1972
  • [3] Prevention Therapy for Breast Cancer: How Can We Do Better?
    Wood, Marie E.
    Cuke, Melissa
    Bedrosian, Isabelle
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (07) : 1970 - 1972
  • [4] Biosimilars in the Treatment of Breast Cancer
    Balic, Marija
    Bartsch, Rupert
    Vrbanec, Damir
    Bauernhofer, Thomas
    Vrdoljak, Eduard
    [J]. BREAST CARE, 2017, 12 (03) : 192 - 194
  • [5] How can information on the risk of breast cancer and hormone therapy be better understood?
    Machado, R. B.
    Santana, N.
    Arruda, L. F.
    Reggi, N.
    Gandolpho, A. C.
    de Moraes, S. Siani
    [J]. CLIMACTERIC, 2015, 18 (04) : 545 - 550
  • [6] Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars
    Uifalean, Alina
    Ilies, Maria
    Nicoara, Raul
    Rus, Lucia Maria
    Heghes, Simona Codruta
    Iuga, Cristina-Adela
    [J]. PHARMACEUTICS, 2018, 10 (04)
  • [7] Time for a change in breast cancer therapy
    Cameron, D
    [J]. HOSPITAL MEDICINE, 2004, 65 (12): : 724 - 729
  • [8] The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?
    Hu Z.I.
    McArthur H.L.
    Ho A.Y.
    [J]. Current Breast Cancer Reports, 2017, 9 (1) : 45 - 51
  • [9] How high a bar to change neoadjuvant therapy for triple-negative breast cancer?
    Kuritzky, Benjamin
    Sikov, William M.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2015, 4 (04) : 293 - 296
  • [10] Can radiation therapy for breast cancer be avoided?
    Sacchini, V
    Borgen, PI
    [J]. LANCET, 2004, 364 (9438): : 916 - 917
12345